Status:
COMPLETED
Evaluation of a Hemostatic and Sealing Agent to Prevent Surgical Complications After Axillary Lymphadenectomy
Lead Sponsor:
Hospital Universitario Virgen de la Arrixaca
Conditions:
Seroma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study was intended to assess the value of a hemostatic and sealing agent, a collagen sponge coated with human coagulation factors (fibrinogen and thrombin) (TachoSil®), for decreasing occurrence ...
Eligibility Criteria
Inclusion
- Patients with axillary lymphadenectomies performed for oncological conditions.
Exclusion
- Patients that did not want to participate in the study.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00852826
Start Date
January 1 2008
End Date
November 1 2008
Last Update
February 27 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario "Virgen de la Arrixaca"
Murcia, Murcia, Spain, 30120